View More Recent Stories
-
Apellis Pharmaceuticals (APLS) PT Lowered to $86 at Baird
-
Apellis Pharmaceuticals (APLS) PT Lowered to $65 at Oppenheimer
-
Apellis Pharmaceuticals (APLS) PT Lowered to $49 at Mizuho
-
Apellis Pharmaceuticals (APLS) to Seek Re-Examination Following Negative EU CHMP Opinion for Pegcetacoplan

